BLFS : Summary for BioLife Solutions, Inc. - Yahoo Finance

U.S. Markets close in 5 hrs 59 mins

BioLife Solutions, Inc. (BLFS)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.57-0.08 (-4.85%)
As of 9:30 AM EST. Market open.
People also watch:
CAPNAKERBSPMBLPHCLRB
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close1.65
Open0.00
Bid1.55 x 1900
Ask1.64 x 200
Day's Range1.57 - 1.57
52 Week Range1.43 - 3.58
Volume74
Avg. Volume56,949
Market Cap20.22M
Beta0.66
PE Ratio (TTM)-4.21
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube22 days ago

    ETFs with exposure to BioLife Solutions, Inc. : November 16, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to BioLife Solutions, Inc. Here are 5 ETFs with the largest exposure to BLFS-US. Comparing the performance and risk of BioLife Solutions, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • BioLife Solutions, Inc. :BLFS-US: Earnings Analysis: Q3, 2016 By the Numbers : November 15, 2016
    Capital Cube23 days ago

    BioLife Solutions, Inc. :BLFS-US: Earnings Analysis: Q3, 2016 By the Numbers : November 15, 2016

    Categories: Yahoo Finance Get free summary analysis BioLife Solutions, Inc. reports financial results for the quarter ended September 30, 2016. Highlights Summary numbers: Revenues of USD 2.14 million, Net Earnings of USD -0.97 million. Gross margins narrowed from 59.65% to 56.87% compared to the same period last year, operating (EBITDA) margins now -48.96% from -74.12%. Change in operating ... Read more (Read more...)

  • American City Business Journals24 days ago

    Biolife Solutions posts record Q3 revenue

    BioLife Solutions posted record revenue for the third quarter. The fast-growing Bothell biotech reported revenue of $2.1 million in the third quarter, driven by sales of two high-demand products that store frozen tissue samples for cancer research. BioLife (BLFS) earlier this year inked 10-year deals with Bellicum Pharmaceuticals (BLCM) and Kite Pharma Inc. (KITE) to supply the companies with materials for transporting delicate biological samples used in their cancer-fighting therapies.